The final, formatted version of the article will be published soon.
BRIEF RESEARCH REPORT article
Front. Cell Death
Sec. Non-Apoptotic Regulated Cell Death
Volume 3 - 2024 |
doi: 10.3389/fceld.2024.1507960
ATF4-mediated expression of NOXA is critical for Necroptosis driven by Glucose Deprivation
Provisionally accepted- 1 National Institutes of Health (NIH), Bethesda, United States
- 2 Chulalongkorn University, Bangkok, Bangkok, Thailand
Glucose deprivation (GD), a common metabolic stress condition, has been recognized as a potent inducer of necroptotic cell death. Our previous findings suggested that the mitochondrial protein, Noxa, may be involved in mediating the release of mitochondrial DNA during GD-induced ZBP1-dependent necroptotic pathway. However, the functional significance of Noxa in necroptosis under GD treatment remains unclear. Here, we investigated the role of Noxa in GD-induced necroptosis and the underlying molecular mechanisms governing its expression. We revealed that Noxa is required for the induction of necroptosis under GD. We also demonstrated that the upregulation of Noxa induced by GD is mediated by ATF4, a key transcription factor. These results provide insights into the regulatory mechanisms underlying Noxa dynamics during GD treatment and highlights its potential as a therapeutic target in cancer therapy and necroptosis-related diseases.
Keywords: glucose deprivation, Noxa, ATF4, necroptosis, Cell Death
Received: 08 Oct 2024; Accepted: 17 Dec 2024.
Copyright: © 2024 Choksi, Sonkaew, Rajna, Yan, Liu, Jitkaew and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Swati Choksi, National Institutes of Health (NIH), Bethesda, United States
Zhenggang Liu, National Institutes of Health (NIH), Bethesda, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.